LinkedIn的分享页面

Decentralised & hybrid clinical trials

患者的重点研究更好的结果

With the rising cost and time to bring new drugs to market and more recently the pandemic outbreak, the demand for decentralised and hybrid trials has risen. These alternative trial models can range in shape and form to include digital health technologies, in-home clinical visits and remote monitoring.

分散和杂交临床试验

分散和杂交临床试验

分散和杂交临床试验have been prevalent for years, yet sponsors have struggled to execute these patient-centric trials effectively. Explore the perceived barriers and how you can make these models a feasible option for the future.

Read the whitepaper
患者的透视 - 分散和杂交试验

患者的透视 - 分散和杂交试验

病人想要什么?2019年,ICON通过其全球研究网站网络进行了基于网络的调查,Accellacare,为了让患者视图并学习将审判患者提供对患者的差异有所不同。凭借超过4,000名患者的反应,我们探讨了关于患者更容易参与临床试验并确定行业感知是否现实的东西的看法和偏好。

阅读报告

Building resilience in pharma R&D by decentralising and digitising

Covid-19爆发推动了对更具弹性的临床试验的渴望。远程临床监测的部署正在证明其有助于在网站管理特别具有挑战性的时候进行试验。但实现这一转型需要灵活的心态,对新技术的投资,并在利益相关者之间密切合​​作。

访问网络研讨会录制
Advancing digital endpoints

Advancing digital endpoints

虽然MHEALTE设备和传感器正在继续发展,但现在可以捕获大量的生理数据,数字试验的运作并非没有挑战。导航由传统试用模型转移到敏捷,以数字健康技术驱动的患者为中心的流程。

Read the whitepaper
敏捷临床监测

敏捷临床监测

During COVID-19 the levels of remote monitoring increased due to site closures and safety reasons. Now is the time to learn from that experience and review whether a hybrid model of remote monitoring and centralised monitoring is the way forward for some trials. Learn best practices in analysing and assessing risk in clinical monitoring and how to remain agile adapting to environmental conditions and therapeutic focus.

Read the whitepaper
MHealth&可穿戴设备

MHealth&可穿戴设备

Understand how to implementwearable devicesand harness digital endpoints in clinical trials:

分散和混合试验视频

ICON's solutions in decentralised and hybrid clinical trials

Decentralised and hybrid trials bring a wide range of benefits to the patient and the sponsor. Find out more about the range of decentralised and hybrid trials services available from ICON.

阅读更多关于图标服务bob体育手机的更多信息